Actual Medicinal Product (AMP) - Vyndaqel 20mg capsules (Pfizer Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Vyndaqel 20mg capsules | Start Date 05-03-2013 | End Date |
Summary
- Licensed Route
- Oral
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
- EMA Monitoring
Codes
| BNF | Start Date | End Date |
|---|---|---|
| Previous BNF 04090300 | Start Date 25-09-2013 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 22112211000001104 | 05-03-2013 |
Parent Products
-
VTMTafamidis
-
VMPTafamidis meglumine 20mg capsules
-
AMP(Current) Vyndaqel 20mg capsules (Pfizer...
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 30 capsule | 1068500 |